Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences

AUSTIN, Texas, Sept. 22, 2017 -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the Ladenburg Thalmann 2017 Healthcare Conference, and the Cantor Fitzgerald Global Healthcare Conference.

Ladenburg Thalmann Healthcare Conference
Date:               Tuesday, September 26
Time:               1:30pm Eastern Time
Location:         Sofitel Hotel New York, Odeon Ballroom
Webcast:         http://wsw.com/webcast/ladenburg3/mtem/

Cantor Fitzgerald Healthcare Conference
Date:               Wednesday, September 27
Time:               4:35pm Eastern Time
Location:         InterContinental New York Barclay Hotel, Empire Ballroom 2
Webcast:         http://wsw.com/webcast/cantor6/mtem/

About Molecular Templates 
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at ​www.mtem.com​.

Investor Contact:
Andrew McDonald, Ph.D.
[email protected]
646-597-6987